tiprankstipranks
Trending News
More News >
Rhino Biotech Limited (RBRXF)
:RBRXF
US Market

Rhino Biotech Limited (RBRXF) Financial Statements

Compare
0 Followers

Rhino Biotech Limited Financial Overview

Rhino Biotech Limited's market cap is currently $144.25K. The company's EPS TTM is $; its P/E ratio is ―; Rhino Biotech Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -21.23K$ -20.42K$ -13.87K
EBITDA$ -21.23K$ 0.00$ 0.00
Net Income$ -21.23K$ -20.42K$ -13.87K
Balance Sheet
Cash & Short-Term Investments$ 1.39K$ 0.00$ 0.00
Total Assets$ 1.39K--
Total Debt$ 41.39K$ 35.32K$ 15.00K
Net Debt$ 39.99K$ 33.80K$ 13.13K
Total Liabilities$ 61.70K$ 40.60K$ 20.52K
Stockholders' Equity$ -60.31K$ -39.08K$ -18.66K
Cash Flow
Free Cash Flow$ -16.00K$ -20.67K$ -17.16K
Operating Cash Flow$ -16.00K$ -20.67K$ -17.16K
Investing Cash Flow$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 15.87K$ 20.32K$ 15.00K
Currency in USD

Rhino Biotech Limited Earnings and Revenue History

Rhino Biotech Limited Debt to Assets

Rhino Biotech Limited Cash Flow

Rhino Biotech Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis